Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hayat Pharmaceutical Industries CoAMM:HPIC 49 5-Year Yield-on-Cost % is 9.61 as of Jul. 28, 2026, which is 9% below its 10-year median of 10.55. GuruFocus rates AMM:HPIC with a GF Score™ of 49/100. The stock has 9 warning signs investors should review. Among 514 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks better than 88.13% on this metric.
The historical rank and industry rank for Hayat Pharmaceutical Industries Co's 5-Year Yield-on-Cost % or its related term are showing as below:
AMM:HPIC'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 4.29 Med: 10.55 Max: 16.86
Current: 9.61
During the past 13 years, Hayat Pharmaceutical Industries Co's highest Yield on Cost was 16.86. The lowest was 4.29. And the median was 10.55.
AMM:HPIC's 5-Year Yield-on-Cost % is ranked better than 88.13% of 514
companies
in the Drug Manufacturers industry
Industry Median: 2.295
vs AMM:HPIC: 9.61
Hayat Pharmaceutical Industries Co (AMM:HPIC) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Hayat Pharmaceutical Industries Co 5-Year Yield-on-Cost % Related Terms
AMM:HPIC vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hayat Pharmaceutical Industries Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Hayat Pharmaceutical Industries Co's 5-Year Yield-on-Cost % falls into.
Hayat Pharmaceutical Industries Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a 5-Year Yield-on-Cost % of 9.61 as of Jul. 28, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hayat Pharmaceutical Industries Co and its competitors. This is near median its historical median of 10.55. Over the past decade, Hayat Pharmaceutical Industries Co's 5-Year Yield-on-Cost % has ranged from 4.29 to 16.86. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #61 out of 514 companies in the Drug Manufacturers industry, placing it in the top 11.9%.
Is Hayat Pharmaceutical Industries Co's 5-Year Yield-on-Cost % too high?
Hayat Pharmaceutical Industries Co's current 5-Year Yield-on-Cost % of 9.61 is near median its 10-year median of 10.55. Over the past 10 years, this metric has ranged from a low of 4.29 to a high of 16.86. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.30. Hayat Pharmaceutical Industries Co's value of 9.61 is 318.7% above this industry median. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #61 out of 514 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #61 out of 514 companies for 5-Year Yield-on-Cost %. This places Hayat Pharmaceutical Industries Co in the top 12% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.30. Hayat Pharmaceutical Industries Co's value of 9.61 is 318.7% above this benchmark. Historically, Hayat Pharmaceutical Industries Co's own 5-Year Yield-on-Cost % has ranged from 4.29 to 16.86 over the past decade. While the company's 10-year median is 10.55 vs. the industry median of 2.30, Hayat Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.30, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hayat Pharmaceutical Industries Co's current 5-Year Yield-on-Cost % of 9.61 is 318.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current 5-Year Yield-on-Cost % is 9.61, which is near median its own 10-year median of 10.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a current 5-Year Yield-on-Cost % of 9.61. The current 5-Year Yield-on-Cost % is 9.61, which is near median its 10-year median of 10.55 and 318.7% above the Drug Manufacturers industry median of 2.30. Hayat Pharmaceutical Industries Co's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current 5-Year Yield-on-Cost % is 9.61 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hayat Pharmaceutical Industries Co Business Description
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
49GF Score
Get the complete analysis for AMM:HPIC
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:HPIC has been successfully added to your 
